An international leader in patient adherence and behavioural change solutions to pharmaceutical companies, public health and health insurers, with offices in US, UK, Germany, Australia and New Zealand.
A veterinary business with clinics throughout Hong Kong and in Singapore.
Medical device development
Developing a device for screening of colon cancer. Minority stake.
Developing a proprietary technology to predict likely responders to cancer immunotherapies and designing next generation targeted immunotherapies.
A Canadian company leveraging computer vision and high-content screening to develop the next wave of therapeutic antibodies.
Digital therapeutics company developing a software-based treatment that improves symptoms in patients with chronic gastro-intestinal conditions.
Develops artificially intelligent clinical decision support software for lung cancer diagnosis and treatment.
A fast-growing provider of dental aligners to consumers in Asia, Australasia and Europe. Invested in Series A round.
A leading provider of IVF and related fertility services in the UK and Poland. Sold in March 2019 to Nordic-based investment company Impilo
Creator of digital products to change the way people look at, deal with and take control of their mental wellbeing. Sold to Medopad (rebranded as Huma).
One of the largest chains of dental clinics in Singapore.